Xing, Jiajun
Li, Baochao
Wang, Songbo
Wang, Zengjun
Miao, Chenkui
Funding for this research was provided by:
Jiangsu Province Capability Improvement Project through Science, Technology and Education (ZDXK202219)
National Natural Science Foundation of China (82203115)
Article History
Received: 4 June 2025
Accepted: 27 August 2025
First Online: 30 September 2025
Declarations
:
: Informed written consent was obtained from all patients. The collection and analysis of tumor and clinical data were approved by the Ethics Committee of Nanjing Medical University (approval No. 2021-SR-430), and the research adhered to established ethical standards. Animal studies were conducted following approval from the Institutional Animal Care and Use Committee (IACUC) of Nanjing Medical University (approval No. 2406068). The construction of the xenotransplantation model complied with institutional guidelines and received approval from the IACUC of Nanjing Medical University.
: All the authors consent for this manuscript publication.
: The authors declare no competing interests.